Search
Fontolizumab
go.drugbank.com/drugs/DB05111InvestigationalFontolizumab (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.
Andrographolide
go.drugbank.com/drugs/DB05767InvestigationalAndrographolide (HMPL-004) is a botanical product extracted from a herb that occurs naturally in China. The herb has an extensive history of use in TCM for the treatment of upper respiratory tract infections and other inflammatory and in...
Categories: Analgesics, Non-NarcoticEthenzamide
go.drugbank.com/drugs/DB13544InvestigationalSynonyms: o-EthoxybenzamideCategories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSOSI-461
go.drugbank.com/drugs/DB05415InvestigationalOSI-461 is a second-generation molecule belonging to a new class of drugs termed selective apoptotic anti-neoplastic drugs (SAANDs).
Allogenic Human Umbilical Derived Mesenchymal Stem Cells in Conditioned Media
go.drugbank.com/drugs/DB15728ExperimentalIn comparison to bone-marrow derived MSCs, these cells are more resilient, easier to extract, and generally regarded as less immunogenic. … Umbilical-cord derived MSCs are currently being tested for numerous clinical applications due to their immunosuppressive and anti-inflammatory properties.
ONO-5334
go.drugbank.com/drugs/DB19206InvestigationalONO-5334 is under investigation in clinical trial NCT00532337 (Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis).
Synonyms: N-((1S)-3-((2Z)-2-((4R)-3,4-DIMETHYL-1,3-THIAZOLIDIN-2-YLIDENE)HYDRAZINO)-2,3-DIOXO-1-(TETRAHYDRO-2H-PYRAN-4YL)PROPYL)CYCLOHEPTANECARBOXAMIDEEltenac
go.drugbank.com/drugs/DB20457ExperimentalEltenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Eltenac is a anti-inflammatory agent, ibufenac derivative. Eltenac has a monoisotopic molecular weight of 300.97 Da.
Categories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalMarimastat
go.drugbank.com/drugs/DB00786InvestigationalUsed in the treatment of cancer, Marmiastat is an angiogenesis and metastasis inhibitor. As an angiogenesis inhibitor it limits the growth and production of blood vessels. As an antimetatstatic agent it prevents malignant cells from brea...
LY-517717
go.drugbank.com/drugs/DB05713InvestigationalIt is believed to be Lilly's PMD-3112 (licensed from Amgen).
Telazorlimab
go.drugbank.com/drugs/DB16374InvestigationalTelazorlimab is under investigation in clinical trial NCT03568162 (Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis).